“Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment”. Tanzania Medical Journal 31, no. 3 (October 7, 2020): 1–14. Accessed May 14, 2025. https://www.tmj.or.tz/index.php/tmj/article/view/359.